Freeze the Clock: Earlier Catheter Ablation for Atrial Fibrillation Delivers Better Outcomes
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Tonnesen J, Ruwald M, Pallisgaard J, Rasmussen P, Johannessen A, Hansen J
. Lower Recurrence Rates of Atrial Fibrillation and MACE Events After Early Compared to Late Ablation: A Danish Nationwide Register Study. J Am Heart Assoc. 2024; 13(7):e032722.
PMC: 11179760.
DOI: 10.1161/JAHA.123.032722.
View
2.
Xintarakou A, Tzeis S, Psarras S, Asvestas D, Vardas P
. Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps. Europace. 2020; 22(3):342-351.
DOI: 10.1093/europace/euaa009.
View
3.
Morillo C, Verma A, Connolly S, Kuck K, Nair G, Champagne J
. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014; 311(7):692-700.
DOI: 10.1001/jama.2014.467.
View
4.
Wazni O, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S
. Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. N Engl J Med. 2020; 384(4):316-324.
DOI: 10.1056/NEJMoa2029554.
View
5.
Kuniss M, Pavlovic N, Velagic V, Hermida J, Healey S, Arena G
. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation. Europace. 2021; 23(7):1033-1041.
PMC: 8286851.
DOI: 10.1093/europace/euab029.
View